BiomX (PHGE) Intangibles (2020 - 2025)
BiomX (PHGE) posted Intangibles of $15.3 million for Q4 2025, little changed sequentially from $15.3 million in Q4 2024, and little changed YoY from $15.3 million in Q4 2024.
BiomX (PHGE) Intangibles (2020 - 2025) Analysis & Trends
BiomX has reported Intangibles for 5 years, with the latest figure at $15.3 million in Q4 2025.
- Quarterly Intangibles changed 0.0% year-over-year to $15.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $15.3 million, changed 0.0% from the prior year.
- Intangibles was little changed at $15.3 million in Q4 2025 per PHGE's latest filing, from $15.3 million in the prior quarter.
- Over five years, Intangibles peaked at $15.3 million in Q2 2024 and troughed at $382000.0 in Q3 2022.
- A 4-year average of $5.6 million and a median of $2.1 million in 2021 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2025: Intangibles slumped 79.88% in 2022, then changed 0.0% in 2025.
- Over 4 years, Intangibles stood at $1.5 million in 2021, then plunged by 74.85% to $382000.0 in 2022, then surged by 3901.83% to $15.3 million in 2024, then changed by 0.0% to $15.3 million in 2025.
- According to Business Quant data, Intangibles over the past three periods registered $15.3 million, $15.3 million, and $15.3 million for Q4 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 93.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.29 Mn |
| Dec 31, 2024 | 15.29 Mn |
| Jun 30, 2024 | 15.29 Mn |
| Sep 30, 2022 | 382,000.00 |
| Jun 30, 2022 | 760,000.00 |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 2.28 Mn |
| Mar 31, 2021 | 2.66 Mn |
| Dec 31, 2020 | 3.04 Mn |